Abstract
Felbamate inhibits [3H]t-butylbicycloorthobenzoate (TBOB) binding and enhances Cl- current at the gamma-aminobutyric AcidA (GABAA) receptor.
A Kume, L J Greenfield Jr, R L Macdonald and R L Albin
Journal of Pharmacology and Experimental Therapeutics June 1996, 277 (3) 1784-1792;